121 related articles for article (PubMed ID: 2108900)
1. A surface polysaccharide forms when gonococci are converted to serum resistance by cytidine 5'-monophospho-N-acetyl neuraminic acid.
Fox AJ; Curry A; Rowland PL; Lancaster S; Jones DM; Parsons NJ; Cole JA; Smith H
FEMS Microbiol Lett; 1990 Jan; 54(1-3):75-80. PubMed ID: 2108900
[TBL] [Abstract][Full Text] [Related]
2. Sialylation of lipopolysaccharide and loss of absorption of bactericidal antibody during conversion of gonococci to serum resistance by cytidine 5'-monophospho-N-acetyl neuraminic acid.
Parsons NJ; Andrade JR; Patel PV; Cole JA; Smith H
Microb Pathog; 1989 Jul; 7(1):63-72. PubMed ID: 2509853
[TBL] [Abstract][Full Text] [Related]
3. The serum resistance of gonococci in the majority of urethral exudates is due to sialylated lipopolysaccharide seen as a surface coat.
Parsons NJ; Curry A; Fox AJ; Jones DM; Cole JA; Smith H
FEMS Microbiol Lett; 1992 Jan; 69(3):295-9. PubMed ID: 1372874
[TBL] [Abstract][Full Text] [Related]
4. Anaerobic growth and cytidine 5'-monophospho-N-acetylneuraminic acid act synergistically to induce high-level serum resistance in Neisseria gonorrhoeae.
Frangipane JV; Rest RF
Infect Immun; 1993 May; 61(5):1657-66. PubMed ID: 8478054
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of conversion of Neisseria gonorrhoeae to resistance to complement by cytidine 5'-monophospho-N-acetyl neuraminic acid.
Emond JP; Dublanchet A; Goldner M
Antonie Van Leeuwenhoek; 1995; 67(3):281-8. PubMed ID: 7778896
[TBL] [Abstract][Full Text] [Related]
6. The surface structure seen on gonococci after treatment with CMP-NANA is due to sialylation of surface lipopolysaccharide previously described as a 'capsule'.
Fox AJ; Curry A; Jones DM; Demarco de Hormaeche R; Parsons NJ; Cole JA; Smith H
Microb Pathog; 1991 Sep; 11(3):199-210. PubMed ID: 1724790
[TBL] [Abstract][Full Text] [Related]
7. Neisseria gonorrhoeae LPS variation, serum resistance and its induction by cytidine 5'-monophospho-N-acetylneuraminic acid.
Demarco de Hormaeche R; van Crevel R; Hormaeche CE
Microb Pathog; 1991 Apr; 10(4):323-32. PubMed ID: 1716719
[TBL] [Abstract][Full Text] [Related]
8. Interaction of pathogenic Neisseria with host defenses. What happens in vivo?
Rest RF; Liu J; Talukdar R; Frangipane JV; Simon D
Ann N Y Acad Sci; 1994 Aug; 730():182-96. PubMed ID: 8080170
[TBL] [Abstract][Full Text] [Related]
9. Resistance to human serum of gonococci in urethral exudates is reduced by neuraminidase.
Parsons NJ; Cole JA; Smith H
Proc Biol Sci; 1990 Jul; 241(1300):3-5. PubMed ID: 1978333
[TBL] [Abstract][Full Text] [Related]
10. Cytidine 5'-monophospho-N-acetyl neuraminic acid and a low molecular weight factor from human blood cells induce lipopolysaccharide alteration in gonococci when conferring resistance to killing by human serum.
Parsons NJ; Patel PV; Tan EL; Andrade JR; Nairn CA; Goldner M; Cole JA; Smith H
Microb Pathog; 1988 Oct; 5(4):303-9. PubMed ID: 3148816
[TBL] [Abstract][Full Text] [Related]
11. Sialylation of lipopolysaccharide by CMP-NANA in viable gonococci is enhanced by low Mr material released from blood cell extracts but not by some UDP sugars.
Parsons NJ; Constantinidou C; Cole JA; Smith H
Microb Pathog; 1994 Jun; 16(6):413-21. PubMed ID: 7830528
[TBL] [Abstract][Full Text] [Related]
12. Cytidine 5'-monophospho-N-acetylneuraminic acid or a related compound is the low Mr factor from human red blood cells which induces gonococcal resistance to killing by human serum.
Nairn CA; Cole JA; Patel PV; Parsons NJ; Fox JE; Smith H
J Gen Microbiol; 1988 Dec; 134(12):3295-306. PubMed ID: 3151997
[TBL] [Abstract][Full Text] [Related]
13. Growth of Neisseria gonorrhoeae in CMP-N-acetylneuraminic acid inhibits nonopsonic (opacity-associated outer membrane protein-mediated) interactions with human neutrophils.
Rest RF; Frangipane JV
Infect Immun; 1992 Mar; 60(3):989-97. PubMed ID: 1541573
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic CMP-Nonulosonates against Multidrug-Resistant
Gulati S; Schoenhofen IC; Lindhout-Djukic T; Schur MJ; Landig CS; Saha S; Deng L; Lewis LA; Zheng B; Varki A; Ram S
J Immunol; 2020 Jun; 204(12):3283-3295. PubMed ID: 32434942
[No Abstract] [Full Text] [Related]
15. A serum-sensitive, sialyltransferase-deficient mutant of Neisseria gonorrhoeae defective in conversion to serum resistance by CMP-NANA or blood cell extracts.
Bramley J; Demarco de Hormaeche R; Constantinidou C; Nassif X; Parsons N; Jones P; Smith H; Cole J
Microb Pathog; 1995 Mar; 18(3):187-95. PubMed ID: 7565013
[TBL] [Abstract][Full Text] [Related]
16. Lactate enhancement of sialylation of gonococcal lipopolysaccharide and of induction of serum resistance by CMP-NANA is not due to direct activation of the sialyltransferase: metabolic events are involved.
Parsons NJ; Emond JP; Goldner M; Bramley J; Crooke H; Cole JA; Smith H
Microb Pathog; 1996 Sep; 21(3):193-204. PubMed ID: 8878016
[TBL] [Abstract][Full Text] [Related]
17. Serum killing of meningococci and several other gram-negative bacterial species is not decreased by incubating them with cytidine 5'-monophospho-N-acetyl neuraminic acid.
Fox AJ; Jones DM; Scotland SM; Rowe B; Smith A; Brown MR; Fitzgeorge RG; Baskerville A; Parsons NJ; Cole JA
Microb Pathog; 1989 Oct; 7(4):317-8. PubMed ID: 2516218
[No Abstract] [Full Text] [Related]
18. A high Mr factor in human blood which confers serum resistance on gonococci: some properties and synergism with CMP-NANA.
Constantinidou C; Beadle D; Zhou XH; Parsons NJ; Sammons CC; Cole JA; Smith H
Microb Pathog; 1992 Jun; 12(6):421-32. PubMed ID: 1522797
[TBL] [Abstract][Full Text] [Related]
19. Identification by mass spectrometry of CMP-NANA in diffusible material released from high M(r) blood cell fractions that confers serum resistance on gonococci.
Parsons NJ; Ashton PR; Constantinidou C; Cole JA; Smith H
Microb Pathog; 1993 Apr; 14(4):329-35. PubMed ID: 8326856
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation.
Mandrell RE; Lesse AJ; Sugai JV; Shero M; Griffiss JM; Cole JA; Parsons NJ; Smith H; Morse SA; Apicella MA
J Exp Med; 1990 May; 171(5):1649-64. PubMed ID: 1692081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
